Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06579209
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-28
Brief Title:
NAD Oral Supplement Pilot Intervention in Adult Females
Sponsor:
None
Organization:
None
Study Overview
Official Title:
NAD Oral Supplement Pilot Intervention in Adult Females
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if Nicotinamide adenine dinucleotide NAD can influence cognition and biomarkers in healthy cognitively intact women who identify as Latina and are between the ages of 40-80 The main questions it aims to answer are
Will executive function change in response to NAD Will inflammatory markers and serum indicators of neurodegeneration change in response to NAD Researchers will compare individuals receiving the NAD to see if the results differ from those receiving the placebo
Participants will
Complete an online questionnaire Visit the lab for computerized cognitive testing and a blood draw Take NAD or a placebo every day for 4 weeks Visit the lab for computerized cognitive testing and a blood draw
Will executive function change in response to NAD Will inflammatory markers and serum indicators of neurodegeneration change in response to NAD Researchers will compare individuals receiving the NAD to see if the results differ from those receiving the placebo
Participants will
Complete an online questionnaire Visit the lab for computerized cognitive testing and a blood draw Take NAD or a placebo every day for 4 weeks Visit the lab for computerized cognitive testing and a blood draw
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None